hGPR91 antagonist 1

SKU: orb1309575

Description

hGPR91 antagonist 1 is a highly potent and selective inhibitor of the human GPR91 receptor, demonstrating an IC50 of 7 nM. This compound is a valuable research tool for investigating the role of succinate signaling in metabolic disorders, diabetic retinopathy, and hypertension using both cellular and animal models.

Research Area

Pharmacology & Drug Discovery

Key Properties

• CAS Number: 1314796-00-3
• MW: 529.53
• Purity: 99.85% (May vary between batches)
• Formula: C₃₁H₂₃F₄N₃O
• SMILES: C(C(N[C@@H](C)C1=CC=C(C=C1)C2=CC(C(F)(F)F)=C(F)C=C2)=O)C3=CC=C(C4=NC5=C(C=C4)C=CC=N5)C=C3
• Target: Succinate Receptor 1 (SUCNR1)
• Solubility: DMSO:25 mg/mL (47.21 mM)

Bioactivity

• Target IC50:
  GPR91 (human):7 nM
• In Vivo:
  GPR91, a 7TM G-Protein-Coupled Receptor, has been recently deorphanized with succinic acid as its endogenous ligand.Current literature indicates that GPR91 plays role in various pathophysiology including renal hypertension, autoimmune disease and retinal angiogenesis.Starting from a small molecule high-throughput screening hit 1 (hGPR91 IC(50): 0.8 μM)-originally synthesized in Merck for Bradykinin B(1) Receptor (BK(1)R) program, systematic structure-activity relationship study led us to discover potent and selective hGPR91 antagonists e.g. 2c, 4c, and 5 g (IC(50): 7-35 nM;>1000 fold selective against hGPR99, a closest related GPCR;>100 fold selective in Drug Matrix screening).Led to identification of two structurally distinct and orally bio-available lead compounds: 5g (%F: 26) and 7e (IC(50): 180 nM;>100 fold selective against hGPR99;%F: 87).
  Read more...

Storage & Handling

• Storage: -20°C
• Expiration Date: 12 months from date of receipt.
• Disclaimer: For research use only

Alternative Names

Inhibitor, HGPR91, hGPR91 antagonist 1, hGPR-91 antagonist 1, inhibit

Compound Identifiers

PubChem CID

53358775